| Expression pattern: |
DN |
| Associated gene: |
RELN |
| Associated microRNA: |
hsa-miR-214-3p |
| Biological function: |
Promotes sorafenib sensitivity (reduces proliferation and increases apoptosis) in HCC cells; reverses sorafenib resistance in RELN knockout HCC cells. |
| Molecular mechanism: |
Acts as a miRNA sponge for hsa-miR-214-3p to up-regulate RELN expression; affects EMT markers (N-cadherin/E-cadherin) in the context of sorafenib resistance. |
| Biological pathway or process: |
ceRNA regulation (promotes); apoptosis (promotes); proliferation (inhibits); EMT (inhibits); drug resistance (inhibits) |
| Detected method: |
Q
M
|
| Validation methods: |
Microarray; RT-qPCR; Bioinformatics Analysis; Luciferase Reporter Assay; Transfection; CCK8; Annexin V/PI Flow Cytometry; Western Blot |
| Clinical significance: |
- |
| Description: |
hsa_circRNA_102049 is down-regulated in sorafenib-resistant HCC cells. Its overexpression increases sorafenib sensitivity by sponging hsa-miR-214-3p to up-regulate RELN, influencing EMT markers and promoting apoptosis while inhibiting proliferation. |
| Confidence score: |
0.593 |